DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Velcade (Bortezomib) - Death - Suspected Cause - Side Effect Reports

 
 



Index of reports > Death (827)

Below is the selection of side effect reports (a.k.a. adverse event reports) related to Velcade (Bortezomib) death. The selected reports were submitted to the FDA during the sample period of about a year.

 Reports 1 - 30 of 827   Next >>

Possible Velcade side effects in

Reported by a physician from France on 2012-08-27

Patient:

Reactions: Death, Arthralgia, Radiotherapy

Adverse event resulted in: death

Drug(s) suspected as cause:
Velcade



Possible Velcade side effects in

Reported by a physician from Japan on 2012-08-27

Patient:

Reactions: Hypotension

Adverse event resulted in: death

Drug(s) suspected as cause:
Thalidomide
    Dosage: 50 mg, unk
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    Start date: 2012-08-06
    End date: 2012-08-09

Velcade
    Dosage: 1 mg/m2, unk
    Indication: Product Used FOR Unknown Indication
    Start date: 2012-08-06
    End date: 2012-08-09

Other drugs received by patient: Dexamethasone



Possible Velcade side effects in

Reported by a physician from Japan on 2012-08-24

Patient:

Reactions: Hyperkalaemia, Interstitial Lung Disease, Multiple Myeloma

Adverse event resulted in: death

Drug(s) suspected as cause:
Velcade

Other drugs received by patient: Dexamethasone; Methylprednisolone Sodium Succinate; Glucose



Possible Velcade side effects in male

Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-24

Patient: male, weighing 103.1 kg (226.8 pounds)

Reactions: Plasmacytosis, Pneumonia, Mouth Haemorrhage, Pseudomonas Infection, Headache, Disease Progression, Death, Mucosal Inflammation, Pleural Effusion, Depressed Level of Consciousness, Abscess, Lethargy, RIB Fracture

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Cisplatin
    Indication: Multiple Myeloma

Cyclophosphamide
    Indication: Multiple Myeloma

Dexamethasone
    Indication: Multiple Myeloma

Doxorubicin Hydrochloride
    Indication: Multiple Myeloma

Etoposide
    Indication: Multiple Myeloma

Radiation Therapy NOS
    Indication: Multiple Myeloma

Revlimid
    Indication: Multiple Myeloma

Thalidomide
    Indication: Multiple Myeloma

Velcade
    Indication: Multiple Myeloma

Other drugs received by patient: Bendamustine Hydrochloride; Lenalidomide



Possible Velcade side effects in

Reported by a physician from France on 2012-08-23

Patient:

Reactions: Back Pain, Electrocardiogram QT Prolonged, Dyspnoea, Hypotension, Thrombocytopenia

Adverse event resulted in: death, life threatening event, hospitalization

Drug(s) suspected as cause:
Dexamethasone
    Dosage: 20 mg, unk
    Administration route: Oral
    Indication: Multiple Myeloma
    Start date: 2012-05-22
    End date: 2012-05-29

JNJ-26481585
    Dosage: 12 mg, unk
    Administration route: Oral
    Indication: Multiple Myeloma
    Start date: 2012-05-21
    End date: 2012-05-31

Velcade
    Dosage: 2.1 mg, unk
    Indication: Multiple Myeloma
    Start date: 2012-05-22
    End date: 2012-05-29

Other drugs received by patient: Ceftriaxone; Primperan / 00041901 /; Acetaminophen; Zelitrex / 01269701 /; Fentanyl; Atracurium Besylate; Kardegic / 00002703 /; Oxycontin; Oxygen; Tranxene; Primperan / 00041901 /; Bumetanide; Crestor; Primperan / 00041901 /; Hydrocortisone; Ondansetron; Ondansetron; Ondansetron; Importal; Tramadol HCL; Noradrenaline / 00127501 /; Tramadol HCL; Morphine; Furosemide; Midazolam; Tramadol HCL



Possible Velcade side effects in male

Reported by a physician from United States on 2012-08-23

Patient: male

Reactions: Death, Chalazion

Adverse event resulted in: death

Drug(s) suspected as cause:
Cyclophosphamide
    Indication: Multiple Myeloma

Dexamethasone
    Indication: Multiple Myeloma

Lenalidomide
    Indication: Multiple Myeloma

Velcade
    Dosage: 2 mg, 1/week
    Indication: Multiple Myeloma
    Start date: 2009-08-13
    End date: 2012-01-03

Other drugs received by patient: Bisphosphonates; Travoprost



Possible Velcade side effects in 59 year old female

Reported by a physician from United States on 2012-08-22

Patient: 59 year old female, weighing 67.8 kg (149.1 pounds)

Reactions: Embolism, Muscular Weakness, Gastric Haemorrhage, Cardiac Arrest

Adverse event resulted in: death, life threatening event, hospitalization

Drug(s) suspected as cause:
Dexamethasone
    Dosage: 40 mg, cyclic
    Administration route: Oral
    Indication: Amyloidosis
    Start date: 2012-07-09
    End date: 2012-08-09

Melphalan Hydrochloride
    Dosage: 0.22 mg/kg, cyclic
    Administration route: Oral
    Indication: Amyloidosis
    Start date: 2012-07-09
    End date: 2012-08-09

Velcade
    Dosage: 1.3 mg/m2, cyclic
    Indication: Amyloidosis
    Start date: 2012-07-09
    End date: 2012-08-09

Velcade
    Dosage: 1.3 mg/m2, cyclic



Possible Velcade side effects in

Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2012-08-22

Patient:

Reactions: Brain Abscess, Sepsis

Adverse event resulted in: death

Drug(s) suspected as cause:
Velcade



Possible Velcade side effects in

Reported by a physician from France on 2012-08-22

Patient:

Reactions: Lung Disorder

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Bendamustine Hydrochloride
    Dosage: 180 mg, qd
    Indication: Mantle Cell Lymphoma
    Start date: 2012-05-29
    End date: 2012-05-30

Dexamethasone
    Dosage: 40 mg, unk
    Indication: Mantle Cell Lymphoma

Mabthera
    Dosage: 750 mg, unk
    Indication: Mantle Cell Lymphoma
    Start date: 2012-05-29
    End date: 2012-05-29

Velcade
    Dosage: 2.6 mg, qd
    Indication: Mantle Cell Lymphoma
    Start date: 2012-05-29
    End date: 2012-06-08

Other drugs received by patient: Rocephin; Glucophage; Fasturtec; Lasix; Duphalac; Colchicine; Actrapid / 00030501 /; Xanax; Ventolin; Albumin; Atarax; Nexium; Zelitrex / 01269701 /; Tranxene; Bactrim; Imovane; Magnesium Sulfate; Ramipril; Citalopram Hydrobromide; Folic Acid; Oxazepam; Pentoxifylline; Lasix



Possible Velcade side effects in female

Reported by a physician from Japan on 2012-08-22

Patient: female, weighing 51.0 kg (112.2 pounds)

Reactions: Cheyne-Stokes Respiration, Cardiac Failure, Pain, Depressed Level of Consciousness, Platelet Count Decreased, Cardiac Amyloidosis, Liver Disorder

Adverse event resulted in: death, life threatening event, hospitalization

Drug(s) suspected as cause:
Fentanyl-100
    Indication: Cancer Pain
    Start date: 2012-04-25
    End date: 2012-04-25

Velcade
    Start date: 2012-03-26

Velcade
    Start date: 2012-03-19

Velcade
    Indication: Multiple Myeloma
    End date: 2012-04-19

Velcade
    Indication: Renal Amyloidosis
    Start date: 2012-03-23

Velcade
    End date: 2012-04-19

Velcade
    Start date: 2012-03-19

Velcade
    End date: 2012-04-12

Velcade
    Start date: 2012-03-23

Velcade
    Start date: 2012-03-26

Velcade
    End date: 2012-04-12

Velcade
    Start date: 2012-03-26

Velcade
    Start date: 2012-03-16

Velcade
    Start date: 2012-03-23

Velcade
    End date: 2012-04-16

Velcade
    End date: 2012-04-12

Velcade
    End date: 2012-04-09

Velcade
    Start date: 2012-03-16

Velcade
    End date: 2012-04-09

Velcade
    Start date: 2012-03-19

Velcade
    End date: 2012-04-09

Velcade
    End date: 2012-04-16

Velcade
    Indication: Cardiac Amyloidosis
    End date: 2012-04-19

Velcade
    End date: 2012-04-16

Velcade
    Start date: 2012-03-16

Other drugs received by patient: Zyvox; Dopamine HCL; Carvedilol; Tolvaptan; Losartan Potassium; Amiodarone HCL; Dexamethasone Acetate; Lasix; Albumin (Human); Lasix; Azosemide; Forsenid; Trichlormethiazide; Valtrex; Fentanyl Citrate; Azosemide; Eplerenone; AN Unknown Medication; Losartan Potassium; Omeprazole



Possible Velcade side effects in

Reported by a physician from United States on 2012-08-20

Patient:

Reactions: Multi-Organ Failure, Sepsis, Hypoxia

Adverse event resulted in: death, life threatening event

Drug(s) suspected as cause:
Dexamethasone
    Indication: Acute Lymphocytic Leukaemia

Doxorubicin Hydrochloride
    Indication: Acute Lymphocytic Leukaemia

PEG-Asparaginase
    Indication: Acute Lymphocytic Leukaemia

Velcade
    Dosage: 1.3 mg/m2, cyclic
    Indication: Acute Lymphocytic Leukaemia

Vincristine
    Indication: Acute Lymphocytic Leukaemia



Possible Velcade side effects in

Reported by a physician from Germany on 2012-08-20

Patient:

Reactions: Infection

Adverse event resulted in: death, life threatening event, hospitalization

Drug(s) suspected as cause:
Cyclophosphamide
    Dosage: unk
    Indication: Multiple Myeloma
    Start date: 2012-03-26
    End date: 2012-07-05

Dexamethasone
    Dosage: unk
    Indication: Multiple Myeloma
    Start date: 2012-03-26
    End date: 2012-07-05

Velcade
    Dosage: unk
    Indication: Multiple Myeloma
    Start date: 2012-03-26
    End date: 2012-07-05

Other drugs received by patient: Zometa; Amoxicillin



Possible Velcade side effects in 71 year old male

Reported by a physician from United States on 2012-08-20

Patient: 71 year old male, weighing 63.0 kg (138.6 pounds)

Reactions: Diarrhoea, Haemorrhage Intracranial, Platelet Count Decreased

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Decitabine
    Dosage: 20 mg/m2, cyclic
    Indication: Acute Myeloid Leukaemia
    Start date: 2012-06-25
    End date: 2012-08-03

Velcade
    Dosage: 1.3 mg/m2, cyclic
    Indication: Acute Myeloid Leukaemia
    Start date: 2012-06-25
    End date: 2012-08-03

Other drugs received by patient: Laxatives



Possible Velcade side effects in

Reported by a physician from Turkey on 2012-08-20

Patient:

Reactions: Asthma, Pneumonia

Adverse event resulted in: death, life threatening event, hospitalization

Drug(s) suspected as cause:
Velcade
    Dosage: unk
    Indication: Multiple Myeloma
    Start date: 2011-12-22
    End date: 2012-03-12

Velcade
    Dosage: unk
    Start date: 2012-03-22

Other drugs received by patient: Dexamethasone; Dexamethasone; Tiotropium Bromide; Moxifloxacin; Tazobactam; Formoterol Fumarate; Zometa; Clarithromycin; Methylprednisolone; Ceftriaxone Sodium



Possible Velcade side effects in

Reported by a physician from United States on 2012-08-20

Patient:

Reactions: Multi-Organ Failure, Sepsis, Cerebral Ischaemia

Adverse event resulted in: death, life threatening event, hospitalization

Drug(s) suspected as cause:
Dexamethasone
    Indication: Acute Lymphocytic Leukaemia

Doxorubicin Hydrochloride
    Indication: Acute Lymphocytic Leukaemia

PEG-Asparaginase
    Indication: Acute Lymphocytic Leukaemia

Velcade
    Dosage: 1.3 mg/m2, cyclic
    Indication: Acute Lymphocytic Leukaemia

Vincristine
    Indication: Acute Lymphocytic Leukaemia



Possible Velcade side effects in

Reported by a physician from Mexico on 2012-08-20

Patient:

Reactions: Renal Failure, Pulmonary Oedema, Renal Tubular Necrosis

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Velcade

Other drugs received by patient: Dexamethasone; Thalidomide



Possible Velcade side effects in

Reported by a physician from United States on 2012-08-20

Patient:

Reactions: Multi-Organ Failure, Sepsis, Hypoxia, Pleural Effusion

Adverse event resulted in: death, life threatening event

Drug(s) suspected as cause:
Dexamethasone
    Indication: Acute Lymphocytic Leukaemia

Doxorubicin Hydrochloride
    Indication: Acute Lymphocytic Leukaemia

PEG-Asparaginase
    Indication: Acute Lymphocytic Leukaemia

Velcade
    Dosage: 1.3 mg/m2, cyclic
    Indication: Acute Lymphocytic Leukaemia

Vincristine
    Indication: Acute Lymphocytic Leukaemia



Possible Velcade side effects in

Reported by a physician from Italy on 2012-08-20

Patient:

Reactions: Dyspnoea, Anaemia, Pancytopenia, Thrombocytopenia, Asthenia

Adverse event resulted in: death, life threatening event, hospitalization

Drug(s) suspected as cause:
Velcade

Other drugs received by patient: Nitroglycerin; Bisoprolol Fumarate; Dexamethasone; Furosemide; Lasix; Dexamethasone



Possible Velcade side effects in female

Reported by a physician from United States on 2012-08-20

Patient: female, weighing 70.8 kg (155.8 pounds)

Reactions: Abdominal Pain, Hyperpyrexia, Anaphylactic Reaction, Chills, Pain, Hepatic Failure, Transaminases Increased, Splenic Infarction, Loss of Consciousness, Aortic Thrombosis, Off Label Use, Malaise, C-Reactive Protein Increased, Myositis, Dyspnoea, Hypotension, Arrhythmia, Lung Consolidation, Hypophosphataemia, Zygomycosis, Bacteraemia, Ventricular Tachycardia, Hyperammonaemia, Neutropenia, Hepatic Infarction, Shock, Infusion Related Reaction

Adverse event resulted in: death, life threatening event

Drug(s) suspected as cause:
Cytarabine
    Dosage: day 1,8, 15 and 22
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2007-10-23

Decadron Phosphate
    Dosage: day 1
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2007-10-23

Doxil
    Dosage: day 1
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2007-10-23
    End date: 2007-10-23

Methotrexate
    Dosage: day 1
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2005-01-01
    End date: 2007-01-01

PEG-Asparaginase
    Dosage: day 2, 8, 15 and 22
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2007-10-25
    End date: 2007-10-25

Velcade
    Dosage: day 1, 4, 8 and 11
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2007-10-23
    End date: 2007-10-23

Vincristine
    Dosage: day 1,8, 15 and 22
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2007-10-23
    End date: 2007-10-23



Possible Velcade side effects in

Reported by a physician from United States on 2012-08-17

Patient:

Reactions: Vomiting, Cardio-Respiratory Arrest, International Normalised Ratio Increased, Thrombocytopenia

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Dexamethasone
    Dosage: 20 mg, unk
    Administration route: Oral
    Indication: Multiple Myeloma
    Start date: 2012-07-03
    End date: 2012-07-14

Velcade
    Dosage: 1.3 mg, unk
    Indication: Multiple Myeloma
    Start date: 2012-07-03
    End date: 2012-07-13

Other drugs received by patient: Carvedilol; Omeprazole; Calcium; Acenocoumarol; Candesartan Cilexetil; Prednisone TAB; Furosemide; Folic Acid; Movicol / 01053601 /



Possible Velcade side effects in

Reported by a physician from Japan on 2012-08-17

Patient:

Reactions: Cheyne-Stokes Respiration, Cancer Pain, Pain, Cardiac Amyloidosis, Staphylococcal Sepsis, Liver Disorder, Cardiac Failure, Platelet Count Decreased, Depressed Level of Consciousness, Septic Shock

Adverse event resulted in: death, life threatening event, hospitalization

Drug(s) suspected as cause:
Fentanyl
    Dosage: 12.5 unk, unk
    Indication: Cancer Pain
    Start date: 2012-04-25
    End date: 2012-04-25

Velcade
    Dosage: 1.824 mg/m2, unk
    Indication: Multiple Myeloma
    Start date: 2012-03-16
    End date: 2012-04-12

Velcade
    Indication: Renal Amyloidosis

Velcade
    Indication: Cardiac Amyloidosis

Other drugs received by patient: Human Albumin / 01102501 /; Dexamethasone; Losartan Potassium; Furosemide; Eplerenone; Omeprazole; Zyvox; Sennoside / 00571902 /; Dopamine HCL; Pursennid / 00142207 /; Losartan Potassium; Furosemide; Amiodarone Hydrochloride; Valaciclovir; Azosemide; Daikenchuto; Carvedilol; Trichlormethiazide; Azosemide; Tolvaptan



Possible Velcade side effects in

Reported by a physician from Iran (Islamic Republic OF) on 2012-08-16

Patient:

Reactions: Death, Convulsion

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Velcade

Other drugs received by patient: Thalidomide



Possible Velcade side effects in

Reported by a physician from France on 2012-08-16

Patient:

Reactions: Electrocardiogram QT Prolonged, Back Pain, Dyspnoea, Hypotension, Thrombocytopenia

Adverse event resulted in: death, life threatening event, hospitalization

Drug(s) suspected as cause:
Dexamethasone
    Dosage: 20 mg, unk
    Administration route: Oral
    Indication: Multiple Myeloma
    Start date: 2012-05-22
    End date: 2012-05-29

JNJ-26481585
    Dosage: 12 mg, unk
    Administration route: Oral
    Indication: Multiple Myeloma
    Start date: 2012-05-21
    End date: 2012-05-31

Velcade
    Dosage: 2.1 mg, unk
    Indication: Multiple Myeloma
    Start date: 2012-05-22
    End date: 2012-05-29

Other drugs received by patient: Ceftriaxone; Primperan / 00041901 /; Bumetanide; Acetaminophen; Morphine; Atracurium Besylate; Ondansetron; Crestor; Fentanyl; Furosemide; Midazolam; Tranxene; Ondansetron; Tramadol HCL; Noradrenaline / 00127501 /; Hydrocortisone; Importal; Tramadol HCL; Kardegic / 00002703 /; Primperan / 00041901 /; Primperan / 00041901 /; Tramadol HCL; Zelitrex / 01269701 /; Oxycontin; Oxygen; Ondansetron



Possible Velcade side effects in 4 year old female

Reported by a consumer/non-health professional from United States on 2012-08-16

Patient: 4 year old female, weighing 13.7 kg (30.1 pounds)

Reactions: Blood Bilirubin Increased, Hyponatraemia, Hypernatraemia, Caecitis, Hypokalaemia, Hypophosphataemia, Left Ventricular Dysfunction, Cardiac Failure, Ileus, Diarrhoea, Venoocclusive Liver Disease, Hypocalcaemia, Acute Respiratory Distress Syndrome

Adverse event resulted in: death, life threatening event, hospitalization

Drug(s) suspected as cause:
Cytarabine
    Dosage: unk, cyclic

Cytarabine
    Dosage: 100 mg/m2, cyclic
    Indication: Acute Myeloid Leukaemia
    Start date: 2012-06-20
    End date: 2012-07-05

Daunorubicin HCL
    Dosage: 50 mg/m2, cyclic
    Indication: Acute Myeloid Leukaemia
    Start date: 2012-06-20
    End date: 2012-06-24

Etoposide
    Dosage: 100 mg/m2, cyclic
    Indication: Acute Myeloid Leukaemia
    Start date: 2012-06-20
    End date: 2012-06-24

Velcade
    Dosage: 1.3 mg/m2, cyclic
    Indication: Acute Myeloid Leukaemia
    Start date: 2012-06-20
    End date: 2012-06-25



Possible Velcade side effects in 64 year old male

Reported by a physician from United States on 2012-08-16

Patient: 64 year old male, weighing 91.7 kg (201.7 pounds)

Reactions: Fungaemia, Blood Bilirubin Increased, Histiocytosis Haematophagic, Pyrexia, Renal Failure Acute

Adverse event resulted in: death, life threatening event, hospitalization

Drug(s) suspected as cause:
Decitabine
    Dosage: 20 mg/m2, cyclic
    Indication: Acute Myeloid Leukaemia
    Start date: 2012-05-25
    End date: 2012-07-02

Velcade
    Dosage: 1.3 mg/m2, cyclic
    Indication: Acute Myeloid Leukaemia
    Start date: 2012-05-25
    End date: 2012-07-02

Other drugs received by patient: Lisinopril; Pantoprazole; Zolpidem Tartrate; Dilaudid; Metoprolol Tartrate; Cyclobenzaprine; Cefepime; Amlodipine; Atenolol; Oxycodone HCL; Sennosides A+B; Acetylsalicylic Acid SRT; Lactulose; Polyethylene Glycol; Nexium; Clopidogrel; Docusate Sodium; Furosemide; Lorazepam; Vardenafil Hydrochloride (Levitra); Acetaminophen; Calcium Carbonate; Ceftriaxone; Metoclopramide HCL / 00041902 /; Nitroglycerin; Famotidine; Flagyl; Rosuvastatin; Acyclovir; Simethicone; Dexamethasone; Vancomycin



Possible Velcade side effects in

Reported by a physician from United States on 2012-08-15

Patient:

Reactions: Death

Adverse event resulted in: death

Drug(s) suspected as cause:
Cytarabine
    Dosage: unk
    Indication: Acute Lymphocytic Leukaemia

Decadron
    Dosage: 10 mg/m2, cyclic
    Administration route: Oral
    Indication: Acute Lymphocytic Leukaemia

Doxorubicin Hydrochloride
    Dosage: 60 mg/m2, cyclic
    Indication: Acute Lymphocytic Leukaemia

Hydrocortisone
    Indication: Acute Lymphocytic Leukaemia

Methotrexate
    Dosage: unk, cyclic
    Indication: Acute Lymphocytic Leukaemia

Oncaspar
    Dosage: unk, cyclic
    Indication: Acute Lymphocytic Leukaemia

Velcade
    Dosage: 1.3 mg/m2, cyclic
    Indication: Acute Lymphocytic Leukaemia

Vincristine
    Dosage: 1.5 mg/m2, cyclic
    Indication: Acute Lymphocytic Leukaemia



Possible Velcade side effects in

Reported by a physician from Japan on 2012-08-15

Patient:

Reactions: Off Label Use, Lung Disorder, Cerebral Infarction, Cardiac Failure, Shock Haemorrhagic, Myocardial Haemorrhage, Duodenal Ulcer Haemorrhage, Ventricular Fibrillation

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Dexamethasone
    Dosage: unk
    Indication: Leukaemia Plasmacytic
    Start date: 2012-04-17
    End date: 2012-05-13

Velcade
    Dosage: 1.3 mg, unk
    Indication: Leukaemia Plasmacytic
    Start date: 2012-04-20
    End date: 2012-04-30

Other drugs received by patient: Lactulose; Rebamipide



Possible Velcade side effects in

Reported by a physician from Korea, Republic of on 2012-08-15

Patient:

Reactions: Death

Adverse event resulted in: death

Drug(s) suspected as cause:
Dexamethasone
    Dosage: 40 mg, cyclic
    Indication: Multiple Myeloma

Doxorubicin Hydrochloride
    Dosage: 9 mg/m2, cyclic
    Indication: Multiple Myeloma

Velcade
    Dosage: 1.3 mg/m2, cyclic
    Indication: Multiple Myeloma

Other drugs received by patient: Neupogen



Possible Velcade side effects in

Reported by a physician from United States on 2012-08-15

Patient:

Reactions: Death

Adverse event resulted in: death

Drug(s) suspected as cause:
Cytarabine
    Dosage: unk
    Indication: Acute Lymphocytic Leukaemia

Decadron
    Dosage: 10 mg/m2, cyclic
    Administration route: Oral
    Indication: Acute Lymphocytic Leukaemia

Doxorubicin Hydrochloride
    Dosage: 60 mg/m2, cyclic
    Indication: Acute Lymphocytic Leukaemia

Hydrocortisone
    Indication: Acute Lymphocytic Leukaemia

Methotrexate
    Dosage: unk, cyclic
    Indication: Acute Lymphocytic Leukaemia

Oncaspar
    Dosage: unk, cyclic
    Indication: Acute Lymphocytic Leukaemia

Velcade
    Dosage: 1.3 mg/m2, cyclic
    Indication: Acute Lymphocytic Leukaemia

Vincristine
    Dosage: 1.5 mg/m2, cyclic
    Indication: Acute Lymphocytic Leukaemia



Possible Velcade side effects in male

Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-15

Patient: male

Reactions: Death

Adverse event resulted in: death

Drug(s) suspected as cause:
Velcade



 Page 1   Next >>

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017